This information was published on 2026-07-09T08:20:19 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2665877 (IR 1924369) |
| (220) |
23 Jan 2026
|
| (300) |
US, 25 Jul 2025, 99303370
|
| (511) (510) |
Class 5
Therapeutic preparations, namely, cellular immunotherapies for cancer, autoimmune diseases and transplant rejections. Class 42 Medical and clinical research and development services in the field of cellular immunotherapies; consulting services in the field of cellular immunotherapies; medical laboratory, research, pre-clinical, and clinical testing services, namely, providing medical laboratory, research, pre-clinical, and clinical testing services for others. Class 44 Providing information, namely, providing medical and scientific information in the field of cellular immunotherapies; providing medical and scientific information in the field of therapeutic preparations. |
| (540) | SWORD AND SHIELD |
| (550) | Word |
| (730) |
Fate Therapeutics, Inc.
|
Find out more about publications on the About page.